ÂÜÀòÂÒÂ×

Michael Bowen holds a position as a Professor of Translational Neuroscience and Psychopharmacology at the University of Sydney since January 2020. He is also the Co-Founder and Chief Scientific Officer at Kinoxis Therapeutics Pty Ltd since February 2018. Previously, he served as a Senior Lecturer at the School of Psychology and as the Associate Director of Scientific Operations at the Lambert Initiative for Cannabinoid Therapeutics, both at the University of Sydney. He has also been a NHMRC Early Career Fellow at the Brain and Mind Centre and worked as a Research Officer Mental Health and Research Scientist at the Faculty of Pharmacy, all within the University of Sydney.